Prevalence of hypertension in an Iranian population

References

• Whitworth J, World Health Organization ISoHWG. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983–1992
   PubMed Web of Science ®Google Scholar
• Cutler J, Sorlie P, Wolz M, Thom T, Fields L, Roccella E. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52(5):818–827
   PubMed Web of Science ®Google Scholar
• Chobanian A, Bakris G, Black H, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Hypertension. 2003;42(6):1206–1252
   PubMed Web of Science ®Google Scholar
• Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002;40(6):920–927
   PubMed Web of Science ®Google Scholar
• Unwin N, Setel P, Rashid S, et al. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ. 2001;79(10):947–953
   PubMed Web of Science ®Google Scholar
• Oh J, Hong Y, Sung Y, Barret-Conner E. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care. 2004;27:2027–2032
   PubMed Web of Science ®Google Scholar
• Ordunez P, Silva L, Rodriguez M, Robles S. Prevalence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance? Rev Panam Salud Publica. 2001;10:226–231
   PubMedGoogle Scholar
• Wolf-Maier K, Cooper R, Banegas J, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363–2369
   PubMed Web of Science ®Google Scholar
• Kearney P, Whelton M, Reynolds K, Whelton P, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):11–19
   PubMed Web of Science ®Google Scholar
• Hajjar I, Kotchen T. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199–206
   PubMed Web of Science ®Google Scholar
• Haghdoost A, Sadeghirad B, Rezazadehkermani M. Epidemiology and heterogeneity of hypertension in iran: a systematic review. Arch Iranian Med. 2008;11(4):444–452
   Google Scholar
• Mohammadi E, Abedi H, Gofranipour F, Jalali F. Partnership caring: a theory of high blood pressure control in Iranian hypertensives. Int J Nurs Pract. 2002;8:324–329
   Google Scholar
• Whelton P. Epidemiology of hypertension. Lancet. 1994;344:101–106
   PubMed Web of Science ®Google Scholar
• Malekzadeh R, Mohamadnejad M, Merat S, Pourshams A, Etmadi A. Obesity pandemic: an Iranian perspective. Arch Iranian Med. 2005;8:1–7
   Google Scholar
• Bahrami H, Sadatsafavi M, Pourshams A, et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health. 2006;6:158--166
   Google Scholar
• Ghanbarian A, Rezaei-Ghaleh N, salehi P, Azizi F. Blood pressure distribution in an Iranian adolescent population: “Tehran Lipid and Glucose study”. Med J Malaysia. 2006;61(4):433–437
   Google Scholar
• Aghaei Meybodi H, Heshmat R, Maasoumi Z, et al. Iranian osteoporosis research network: background, mission and its role in osteoporosis management. Iranian J Publ Health. 2008;1:1–6
   Google Scholar
• Tuan N, Adair L, He K, Popkin B. Optimal cutoff values for overweight: using body mass index to predict incidence of hypertension in 18–65-year-old Chinese adults. J Nutr. 2008;138(7):1377–13782
   Google Scholar
• Lohman T, Roche A, Martorell R. Anthropometrical Standardization Reference Manual. Champaign: Human Kinetics Books; 1988
   Google Scholar
• Lau D, Douketis J, Morrison K, et al. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ. 2007;176(8 suppl):1–117
   Google Scholar
• Kearney P, Whelton M, Reynolds K, Munter P, Whelton P, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223
   PubMed Web of Science ®Google Scholar
• Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A. Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. J Hypertens. 2000;18(5):521–529
   PubMed Web of Science ®Google Scholar
• Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health. 2005;4(1):2--9
   PubMedGoogle Scholar
• Lopez A, Mathers C, Ezzati M, Jamison D, Murray C. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–1757
   PubMed Web of Science ®Google Scholar
• EMRO. The Forty-Ninth Session of the WHO Regional Committee Regional Office for the Eastern Mediterranean in Cairo; 2002
   Google Scholar
• Al-Nozha M, Ali M, Osman A. Arterial hypertension in Saudi Arabia. EMHJ. 1998;4(382):170–174
   Google Scholar
• Al-Hosani H. Health for all in the United Arab Emirates. EMHJ. 2000;6(838):838--840
   Google Scholar
• Hasab A, Jaffer A, Hallaj Z. Blood pressure patterns among the Omani population. EMHJ. 1999;5:46–54
   Google Scholar
• Al Riyami A, Afifi M. Hypertension in Oman: distribution and correlates. J Egypt Public Health Assoc. 2002;77(3–4):383–407
   Google Scholar
• El-Reshaid K, Al-Owaish R, Diab A. Hypertension in Kuwait: the past, present and future. Saudi J Kidney Dis Transpl. 1999;10(3):357–364
   Google Scholar
• Al-Said J. The prevalence of hypertension in Persian Gulf countries and its correlation with demographic and socio-economic factors. J Hypertens. 2005;23(6):1275–1277
   Google Scholar
• Esteghamati A, Meysamie A, Khalilzadeh O, et al. Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9:167–177
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Abbasi M, Alikhani S, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens. 2008;21(6):620–626
   Google Scholar
• Azizi F, Esmaillzadeh A, Mirmiran P. Obesity and cardiovascular risk factors: an epidemiological study in Tehran. Iran J Endocrinol Metabol. 2004;5(suppl 4):389–397
   Google Scholar
• Mirmiran P, Azadbakht L, Azizi F. The predictors of cardiovascular risk factors in adolescents: Tehran Lipid and Glucose Study. J Shaheed Beheshti Univ Med Sci Health Serv. 2003;3:175–184
   Google Scholar
• Navaei L, Mehrabi Y, Kimiagar M, Azizi F. Epidemiologic survey on hypertension and its relation with obesity, diabetes, and hyperlipidemia in Islamshahr, Iran. J Shaheed Beheshti Univ Med Sci Health Serv. 1998;2:40–52
   Google Scholar
• Navaii L, Mehrabi Y, Azizi F. An epidemiologic study of hyperlipidemia, obesity, and hypertension in Tehran villages. Iranian J Endocrinol Metabol. 2000;8:253–263
   Google Scholar
• Azizi F, Saadat N, salehi P, Emami H. Glucose intolerance and cardiovascular risk factors in Tehran urban population: “Tehran Lipid and Glucose Study”. Iran J Endocrinol Metabol. 2001;12:247–256
   Google Scholar
• Azizi F, Emami H, salehi P, Ghanbarian A, Mirmiran P, Mirbolooki M. Cardiovascular risk factors in the elderly: Tehran Lipid and Glucose Study (TLGS). Iran J Endocrinol Metabol. 2003;17:3–14
   Google Scholar
• Ghanbarian A, Majid M, Rahmani M, Sarraf-Zadeh A, Azizi F. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study. Iran J Endocrinol Metabol. 2003;17:425–435
   Google Scholar
• Efstratopoulos A, Voyaki S, Baltas A, et al. Prevalence, awareness, treatment, and control of hypertension in Hellas, Greece. Am J Hypertens. 2006;19(1):53–60
   PubMed Web of Science ®Google Scholar
• Sadeghi M, Roohafza H, Kelishadi R. Blood pressure and associated cardiovascular risk factors in Iran: Isfahan Healthy Heart Programme. Med J Malaysia. 2004;59(4):460–467
   Google Scholar
• Altun B, Arici M, Nergizoglu G, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens. 2005;23(10):1817–1823
   PubMed Web of Science ®Google Scholar
• Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004;18:73–78
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288:321–333
   PubMed Web of Science ®Google Scholar
• Martiniuk A, Lee C, Lawes C, et al. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens. 2007;25(1):73–79
   Google Scholar
• Al-Nozha M, Abdullah M, Arafah M, et al. Hypertension in Saudi Arabia. Saudi Med J. 2007;28(1):77–84
   PubMed Web of Science ®Google Scholar
• Inamo J, Langb T, Atallahc A, et al. Prevalence and therapeutic control of hypertension in French Caribbean regions. J Hypertens. 2005;23:1341–1346
   PubMed Web of Science ®Google Scholar